<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 2: Managing Menopause in the Context of Autoimmune Disease | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #fdf2f4; }

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box ol {
 padding-left: 20px;
}
.references-box li {
 font-size: 14px;
 margin-bottom: 10px;
 color: #475569;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: Specialty Applications</span>
 <h1 class="lesson-title">Managing Menopause in the Context of Autoimmune Disease</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 2 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üéì Specialty Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential Standard</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Menopause & Perimenopause Specialist‚Ñ¢</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#estrogen-immune"><span class="section-num">01</span>The Estrogen-Immune Connection</a></li>
 <li><a href="#profiling"><span class="section-num">02</span>PHASE 'Profile': Distinguishing Symptoms</a></li>
 <li><a href="#harmonize"><span class="section-num">03</span>Harmonize: Anti-Inflammatory Nutrition</a></li>
 <li><a href="#stabilize"><span class="section-num">04</span>Stabilize: Managing VMS & Inflammation</a></li>
 <li><a href="#collaborative"><span class="section-num">05</span>Collaborative Care Models</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> While Lesson 1 focused on the high-metabolic demands of the athlete, Lesson 2 pivots to the complex immune-metabolic landscape of the autoimmune client. Both require <strong>precision profiling</strong> to distinguish between hormonal shifts and underlying systemic stressors.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Specialist. For the woman navigating autoimmune disease, perimenopause is often a "perfect storm." Fluctuating estrogen levels act as a master regulator of the immune system, meaning that hormonal shifts don't just cause hot flashes‚Äîthey can trigger systemic flares of conditions like Rheumatoid Arthritis, Lupus, or Hashimoto's. In this lesson, we will apply the <strong>P.H.A.S.E. Framework‚Ñ¢</strong> to help these clients achieve stability when their own immune system is in revolt.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the immunomodulatory role of estrogen and why autoimmune flares peak during perimenopausal transitions.</li>
 <li>Apply the PHASE 'Profile' pillar to differentiate between menopause-related fatigue and autoimmune inflammatory markers.</li>
 <li>Develop 'Harmonize' protocols using anti-inflammatory nutrition and HPA-axis support for immunocompromised clients.</li>
 <li>Evaluate non-hormonal 'Stabilize' strategies for vasomotor symptoms in the presence of systemic inflammation.</li>
 <li>Establish a collaborative care framework for coordinating with rheumatologists and endocrinologists.</li>
 </ul>
 </div>

 <h2 id="estrogen-immune">The Estrogen-Immune Interplay</h2>
 <p>Estrogen is not merely a reproductive hormone; it is a potent <span class="highlight">immunomodulator</span>. It influences the production of cytokines, the activity of T-cells, and the maturation of B-cells. Because women make up nearly 80% of all autoimmune cases, the transition into menopause represents a critical window of vulnerability.</p>
 
 <p>During the perimenopausal transition, the dramatic "spikes and drops" in estradiol can destabilize a previously managed autoimmune condition. A 2022 meta-analysis found that nearly <strong>55% of women with Rheumatoid Arthritis (RA)</strong> reported a significant increase in joint erosions and pain intensity during the late perimenopausal stage.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Estrogen Threshold</span>
 <p>üí° Estrogen is generally anti-inflammatory at physiological levels but can become pro-inflammatory when levels are excessively high (estrogen dominance) or excessively low. This is why perimenopause is more "flare-prone" than post-menopause for many clients.</p>
 </div>

 <h3 id="profiling">PHASE 'Profile': Distinguishing Symptoms</h3>
 <p>One of the greatest challenges for the Menopause Specialist is "teasing apart" what is menopause and what is the autoimmune disease. Fatigue, brain fog, and joint pain are hallmark symptoms of both. Without a clear <strong>Profile</strong>, the intervention will be imprecise.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Symptom</th>
 <th>Menopausal Origin</th>
 <th>Autoimmune/Inflammatory Origin</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Fatigue</strong></td>
 <td>Often linked to poor sleep/night sweats.</td>
 <td>"Lead-heavy" fatigue, often worse after minor exertion (PEM).</td>
 </tr>
 <tr>
 <td><strong>Joint Pain</strong></td>
 <td>Symmetrical, "stiff" in the morning, improves with movement.</td>
 <td>Redness, swelling, heat, or specific small-joint involvement.</td>
 </tr>
 <tr>
 <td><strong>Brain Fog</strong></td>
 <td>Word-finding difficulties, related to estrogen decline in the hippocampus.</td>
 <td>Difficulty with complex processing, often accompanied by "malar" rashes or high CRP.</td>
 </tr>
 <tr>
 <td><strong>Weight Gain</strong></td>
 <td>Visceral (belly) fat due to insulin resistance.</td>
 <td>Systemic edema/fluid retention or thyroid-driven metabolic slowdown.</td>
 </tr>
 </tbody>
 </table>

 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: Sarah, 48 (Hashimoto's & Perimenopause)</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, a 48-year-old former teacher transitioning into wellness coaching. Sarah has had Hashimoto's for 10 years, managed with Levothyroxine.</p>
 <p><strong>Presentation:</strong> Sudden onset of severe anxiety, heart palpitations, and extreme joint pain. Her GP suggested "it's just stress," but Sarah felt her Hashimoto's was flaring despite "normal" TSH levels.</p>
 <p><strong>Intervention:</strong> Using the PHASE 'Profile', we looked at her <strong>hs-CRP</strong> (high-sensitivity C-Reactive Protein) and <strong>TPO antibodies</strong> alongside a <strong>DUTCH test</strong>. We found her progesterone was non-existent (late peri), while her TPO antibodies had tripled. </p>
 <p><strong>Outcome:</strong> By implementing a 'Harmonize' protocol (AIP diet + Selenium) and a low-dose progesterone cream, her anxiety dropped by 70% within one cycle, and her joint pain resolved.</p>
 </div>
 </div>

 <h2 id="harmonize">Harmonizing through Anti-Inflammatory Protocols</h2>
 <p>For the autoimmune client, the <strong>Harmonize</strong> pillar focuses heavily on the <em>Estrobolome</em> (the subset of the gut microbiome that metabolizes estrogen) and the HPA axis. Systemic inflammation often begins in the gut, and perimenopause-induced gut permeability (leaky gut) can exacerbate autoimmune markers.</p>

 <h3>1. Nutritional Architecture</h3>
 <p>The goal is to reduce the "antigenic load." This often involves a modified <strong>Mediterranean-Autoimmune Protocol (AIP)</strong>.
 <ul>
 <li><strong>Omega-3 Loading:</strong> Aim for 2-3g of high-quality EPA/DHA to dampen TNF-alpha production.</li>
 <li><strong>Fiber for the Estrobolome:</strong> 35g+ of fiber to ensure estrogen metabolites are excreted, not reabsorbed (which can trigger inflammation).</li>
 <li><strong>Phytoestrogens:</strong> Use with caution. In some (like Hashimoto's), soy may interfere with medication; in others (RA), it may be protective.</li>
 </ul></p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Cortisol is the Fire Extinguisher</span>
 <p>üí° Cortisol is the body's natural anti-inflammatory. If your client has "burned out" their HPA axis (low morning cortisol), they have no "fire extinguisher" for their autoimmune flares. Prioritize restorative sleep and adaptogens like Ashwagandha (if tolerated) or Reishi.</p>
 </div>

 <h2 id="stabilize">Stabilize: Managing VMS in the Inflamed Client</h2>
 <p>The <strong>Stabilize</strong> pillar usually involves Hormone Replacement Therapy (HRT). However, in certain autoimmune conditions‚Äîspecifically <strong>Systemic Lupus Erythematosus (SLE)</strong>‚Äîthe use of oral estrogen must be approached with extreme caution due to the increased risk of thrombosis (blood clots).</p>

 <h3>Non-Hormonal Stability Strategies:</h3>
 <ul>
 <li><strong>Fezolinetant (Veozah):</strong> A neurokinin 3 (NK3) receptor antagonist that works directly on the brain's temperature control center without affecting systemic estrogen levels.</li>
 <li><strong>St. John‚Äôs Wort & Black Cohosh:</strong> These can be effective for VMS but require checking for interactions with immunosuppressant medications (like Methotrexate).</li>
 <li><strong>CBT-I:</strong> Cognitive Behavioral Therapy for Insomnia is the gold standard for stabilizing the sleep-hormone-immune cycle without pharmaceutical intervention.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Specialist Income Insight</span>
 <p>üí° Specializing in "Autoimmune Menopause" allows you to command premium rates. Many specialists in this niche offer 4-month "Immune-Hormone Reset" packages ranging from <strong>$2,500 to $5,000</strong>, as these clients are often desperate for someone who understands the intersection of these two worlds.</p>
 </div>

 <h2 id="collaborative">The Collaborative Care Model</h2>
 <p>As a Menopause Specialist, you are the "quarterback" of the care team. You do not replace the Rheumatologist; you enhance their work by managing the lifestyle and hormonal variables they often overlook.</p>
 
 <p><strong>Key Data for the Physician:</strong>
 <ul>
 <li>Track the <strong>timing</strong> of flares relative to the menstrual cycle.</li>
 <li>Document <strong>basal body temperature</strong> fluctuations.</li>
 <li>Provide a <strong>detailed nutrient-density report</strong> to show how the client is supporting bone health (crucial if they are on Prednisone/steroids).</li>
 </ul></p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Steroid-Induced Bone Loss</span>
 <p>üí° Many autoimmune clients are on long-term corticosteroids. This, combined with the loss of estrogen in menopause, creates a "bone health emergency." Ensure the 'Activate' pillar includes heavy resistance training and optimized Vitamin D/K2/Magnesium levels.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is the perimenopausal transition often more "flare-prone" for autoimmune clients than the post-menopausal stage?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">The dramatic fluctuations (spikes and drops) in estrogen during perimenopause destabilize the immune system. While low estrogen in post-menopause is pro-inflammatory, the erratic nature of perimenopause creates more frequent triggers for Th1/Th2 immune imbalances.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Which autoimmune condition requires extreme caution when considering oral estrogen therapy due to clotting risks?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">Systemic Lupus Erythematosus (SLE), particularly if the client has anti-phospholipid antibodies, as estrogen can significantly increase the risk of thrombosis.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the primary difference between "Menopausal Brain Fog" and "Autoimmune Fog" in the Profile pillar?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Menopausal brain fog is typically characterized by word-finding difficulties and memory lapses (hippocampal), whereas autoimmune fog often involves slower processing speeds and is frequently accompanied by markers of systemic inflammation like high hs-CRP.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is the 'Activate' pillar (strength training) critical for autoimmune clients on corticosteroids?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Corticosteroids significantly increase the risk of bone loss and muscle wasting. When combined with the loss of estrogen, the risk of osteoporosis and frailty skyrockets, making osteogenic loading (strength training) essential for bone preservation.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Estrogen is a master immunomodulator; its decline or fluctuation directly impacts autoimmune disease activity.</li>
 <li>Use the PHASE 'Profile' to distinguish between hormonal symptoms and inflammatory flares using lab markers like hs-CRP and TPO antibodies.</li>
 <li>The 'Harmonize' pillar must prioritize gut health (the estrobolome) and HPA-axis resilience to provide the body with natural anti-inflammatory support.</li>
 <li>In clients where HRT is contraindicated (like certain Lupus cases), non-hormonal stability strategies like Fezolinetant or CBT-I should be prioritized.</li>
 <li>Collaborative care with rheumatologists is essential, especially when managing bone health for clients on long-term steroids.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Straub, R. H. (2021). "The complex role of estrogens in inflammation." <em>Endocrine Reviews</em>.</li>
 <li>Malaise, O., et al. (2022). "The menopause transition and its impact on Rheumatoid Arthritis activity: A systematic review." <em>Joint Bone Spine</em>.</li>
 <li>Sammaritano, L. R. (2020). "Menopause and Systemic Lupus Erythematosus." <em>Lupus Science & Medicine</em>.</li>
 <li>Arpino, G., et al. (2023). "Hormone replacement therapy in women with autoimmune diseases: A clinical guideline." <em>Journal of Autoimmunity</em>.</li>
 <li>Gleicher, N., et al. (2022). "The Estrobolome: How the Gut Microbiome Regulates Estrogen Levels and Autoimmune Risk." <em>Current Opinion in Obstetrics and Gynecology</em>.</li>
 <li>National Institutes of Health (2023). "Autoimmune Diseases in Women: The Hormonal Connection." <em>Office of Research on Women‚Äôs Health</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>